综述——纳米材料与药物输递：基因治疗药物输递系统的研究现状及发展趋势

基因治疗是一种有效的治疗方法,可用于治疗多种严重威胁人类健康的疾病．然而,裸露的基因治疗药物存在易被核酶降解、细胞内吞效果差和细胞靶向能力差等缺点．因此,需要寻求合适的载体,将基因治疗药物有效地输递到靶细胞,实现高效的基因治疗．本文主要综述了近年来基因治疗药物输递系统的研究进展,分别总结和阐述了病毒载体,脂质体、聚合物和树状大分子等非病毒载体,以及具有示踪功能的输递系统的特点及研究和发展现状．     

副溶血性弧菌重复序列-PCR分型研究

利用基因外重复回文序列-PCR(REP-PCR)和肠细菌基因间共有重复序列-PCR(ERIC-PCR)技术,对副溶血性弧菌进行了分子分型研究和亲缘关系的探讨,并使用Hunter和Gaston方法计算分辨力指数.结果显示40株副溶血性弧茵分离株均可扩增产生可重复的DNA指纹图谱,并且不同菌株基因组DNA的扩增条带具有多态性.根据SPSS10.0软件得出的树状图结果,REP-PCR可以把40株茵分为21个型,分辨力指数可达到0.953,优势菌型为G1型;ERIC-PCR可将40株菌分成4个型,分辨力指数为0.5.研究显示重复序列-PCR方法可以用于该菌分型分析,REP-PCR具有较好的分型能力.在两种PCR的DNA指纹图谱中,血清型O1群与O3群主条带均非常相似,表明它们之间亲缘关系密切.     

应用树状DNA杂交(DDH)对生殖道尖锐湿疣中HPV DNA的分型检测

从手术切除的50例生殖道尖锐湿疣新鲜标本中,以及15例正常人血清中,提取基因组DNA,同时用树状DNA杂交(dendrimer DNA hybridizalion,DDH)技术和PCR进行HPV DNA的分型检测.结果50例尖锐湿疣中,以DDH方法检测,感染HPV6型者20例,感染11型者24例,6/11型混合感染者3例,阴性3例,总检测率达94%;以PCR方法检测,HPV6型感染者21例,11型感染者24例,6/11型混合感染者3例,阴性2例,总检测率为96%.15例正常人血清中,以DDH方法检测,HPV感染的假阳性率为0%;以PCR检测,假阳性率为6.67%.还以HPV阳性标本对DDH方法做了敏感度的测定,结果阳性病例DNA检测最低浓度为97.28pg/ml.研究表明,DDH技术具有较高敏感性和高特异性,且成本较低,操作安全简便,可适用于基层中小医院较大样本量筛查.     

用RAPD探讨毛白杨起源

利用RAPD分子标记对山杨、欧洲山杨、银白杨、响叶杨及毛白杨的5个不同类型,即抱头毛白杨、截叶毛白杨、易县毛白杨、陕西毛白杨和南京栽培的毛白杨进行了分析,并进行了银白杨×响叶杨正反交实验,研究杂种后代与毛白杨的关系。RAPD分析说明,毛白杨的亲缘关系与银白杨和响叶杨较近,而与山杨和欧洲山杨的亲缘关系则较远。毛白杨在聚类图上首先是与银白杨和响叶杨聚为一类,再与山杨和欧洲山杨聚在一起。通过比较毛白杨与银白杨和响叶杨的正反交子代,发现毛白杨更接近银白杨×响叶杨的子代,而与反交子代有所区别。由此可见,毛白杨为天然杂种是没有疑义的,而且很可能是银白杨×响叶杨的杂种。本研究筛选出的13个引物,产生了78条谱带,覆盖了基因组的一定区域,其可靠性是较高的。     

链格孢属小孢子种的RAPD分析

用筛选出的12个随机引物,对链格孢属Alternaria13个小孢子种和作为对照的3个大孢子种共55个分离系(isolates)进行RAPD分析。大孢子种Alternariasolani、A.porri和形态独特的A.leucanthemi在树状聚类图上遗传距离0.44处与所有供试小孢子种区分开,它们彼此之间在遗传距离0.25处相区分,表明所采用的RAPD分析方法适于链格孢种间亲缘关系的研究。所有供试的链格孢小孢子种在遗传距离0.31水平上被聚在一起,表明它们之间的亲缘关系较近。A.infectoria与其它链格孢小孢子种之间遗传距离较远;A.longipes的3个分离系和A.brassicicola的7个分离系在较低的遗传距离上被聚在一起,表明它们是独立的种。其它供试链格孢小孢子种的不同分离系在树状聚类图上未显示明确区分。     

Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors

Recent developments in tumor immunology and biotechnology have made cancer gene therapy and immunotherapy feasible. The current efforts for cancer gene therapy mainly focus on using immunogenes, chemogenes and tumor suppressor genes. Central to all these therapies is the development of efficient vectors for gene therapy. By far, adenovirus （AdV）-mediated gene therapy is one of the most promising approaches, as has confirmed by studies relating to animal tumor models and clinical trials. Dendritic cells （DCs） are highly efficient, specialized antigen-presenting cells, and DC- based tumor vaccines are regarded as having much potential in cancer immunotherapy. Vaccination with DCs pulsed with tumor peptides, lysates, or RNA, or loaded with apoptotic/necrotic tumor cells, or engineered to express certain cytokines or chemokines could induce significant antitumor cytotoxic T lymphocyte （CTL） responses and antitumor immunity. Although both AdV-mediated gene therapy and DC vaccine can both stimulate antitumor immune responses, their therapeutic efficiency has been limited to generation of prophylactic antitumor immunity against re-challenge with the parental tumor cells or to growth inhibition of small tumors. However, this approach has been unsuccessful in combating well-established tumors in animal models. Therefore, a major strategic goal of current cancer immunotherapy has become the development of novel therapeutic strategies that can combat well-established tumors, thus resembling real clinical practice since a good proportion of cancer patients generally present with significant disease. In this paper, we review the recent progress in AdV-mediated cancer gene therapy and DC-based cancer vaccines, and discuss combined immunotherapy including gene therapy and DC vaccines. We underscore the fact that combined therapy may have some advantages in combating well-established tumors vis-a-vis either modality administered as a monotherapy.     

树状多节孢酸性磷酸酶的分离纯化与性质研究

树状多节孢Nodulisporium sylviforme是从东北红豆杉Taxus cuspidata分离、可产生紫杉醇的内生真菌。研究以树状多节孢为材料,利用液体发酵手段获得菌丝体,通过CM-cellulose阴离子交换柱层析、Q-Sepharose阳离子交换柱层析和FPLC凝胶过滤层析（Superdex 75）,获得纯化的树状多节孢酸性磷酸酶蛋白（Nod-ACP）。结合FPLC和SDS-PAGE分析,判定该磷酸酶为分子量44kDa单亚基蛋白。酶学性质研究表明,其最适pH值为3.0,最适温度为58℃。6     

模糊图论在山西植被区划中的应用

本文用模糊图论的最大树方法对山西植被区划进行了数量分类研究,将山西植被分为2个植被地带,6个植被地区,17个植被小区。与在植物群落学中应用的模糊聚类分析和其它方法相比,模糊图论的最大树方法直接依模糊相似系数矩阵得到树状图,从而避免了相似系数矩阵复杂的合成运算,而分类结果不仅更具直观性,而且也是令人满意的。我们认为模糊图论应用于植被区划是合适的。     

树状单杆菌变株U—616葡萄糖异构酶的研究

以树状黄杆菌ＮＲＲＬ１１０２２为出发菌株,用紫外线对其进行诱变,经筛选得到一株葡萄糖异构酶的高产菌株Ｕ－６１６,其酶活力提高３１％,经保存三年和多次传代复测,其产酶能力保持稳定,其生长和产酶需较高的溶氧水平,最适产酶温度为３０℃,最适产酶ｐＨ为７．０－７．５,铁离子对其生长和产酶无明显的影响。所产葡萄糖异构酶的最适温度为６０￣８０℃,最适ｐＨ为７．５－８．５,Ｃｏ＾２＋和Ｍｇ＾２＋对酶有激活作用,     

IRF family proteins and type I interferon induction in dendritic cells

Dendritic cells （DC）, although a minor population in hematopoietic cells, produce type I interferons （IFN） and other cytokines and are essential for innate immunity. They are also potent antigen presenters and regulate adaptive immunity. Among DC subtypes plasmacytoid DC （pDC） produce the highest amounts of type I IFN. In addition, pro- and anti-inflammatory cytokines such as IL-12 and IL-10 are induced in DC in response to Toll like receptor （TLR） signaling and upon viral infection. Proteins in the IRF family control many aspects of DC activity. IRF-8 and IRF-4 are essential for DC development. They differentially control the development of four DC subsets. IRF-8^-/- mice are largely devoid of pDC and CD8α^＋ DC, while IRF-4^-/- mice lack CD4^＋ DC. IRF-8^-/-, IRF4^-/-, double knock-out mice have only few CD8α CD4^-DC that lack MHC Ⅱ. IRF proteins also control type Ⅰ IFN induction in DC. IRF-7, activated upon TLR signaling is required for IFN induction not only in pDC, but also in conventional DC （cDC） and non-DC cell types. IRF-3, although contributes to IFN induction in fibroblasts, is dispensable in IFN induction in DC. Our recent evidence reveals that type Ⅰ IFN induction in DC is critically dependent on IRF-8, which acts in the feedback phase of IFN gene induction in DC. Type Ⅰ IFN induction in pDC is mediated by MyD88 dependent signaling pathway, and differs from pathways employed in other cells, which mostly rely on TLR3 and RIG-Ⅰ family proteins. Other pro-inflammatory cytokines are produced in an IRF-5 dependent manner. However, IRF-5 is not required for IFN induction, suggesting the presence of separate mechanisms for induction of type Ⅰ IFN and other pro-inflammatory cytokines. IFN and other cytokines produced by activated DC in turn advance DC maturation and change the phenotype and function of DC. These processes are also likely to be governed by IRF family proteins.